C CENCORA INC
| Market Cap | $70.00B |
| P/E Ratio | 43.25 |
| Forward P/E | 18.34 |
| Dividend Yield | 0.67% |
| Beta | 0.65 |
| 52W Range | $251.94 - $377.54 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Medical Distribution |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 0.00% | $0 | 0 | Sold |
Insider Trading
| Insider Name of the company insider who made the trade 11 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Mauch Robert P.President & CEO | Sale | 3,762 | $358.94 | $1.35M | 20 Feb 2026 | 24 Feb 2026 |
| Mauch Robert P.President & CEO | Sale | 1,333 | $359.46 | $479.16K | 18 Feb 2026 | 20 Feb 2026 |
| Mauch Robert P.President & CEO | Sale | 5,096 | $354.73 | $1.81M | 20 Jan 2026 | 22 Jan 2026 |
| Battaglia SilvanaExecutive Vice President | Sale | 1,677 | $345.00 | $578.57K | 19 Dec 2025 | 22 Dec 2025 |
| Campbell Elizabeth SExecutive Vice President | Sale | 3,351 | $342.10 | $1.15M | 19 Dec 2025 | 22 Dec 2025 |
| Mauch Robert P.President & CEO | Sale | 5,096 | $343.45 | $1.75M | 18 Dec 2025 | 22 Dec 2025 |
| Krikorian LazarusSVP & Chief Accounting Officer | Sale | 4,031 | $343.24 | $1.38M | 17 Dec 2025 | 19 Dec 2025 |
| Mauch Robert P.President & CEO | Sale | 5,096 | $366.64 | $1.87M | 18 Nov 2025 | 19 Nov 2025 |
| Robert P. MauchPresident & CEO | Sale | 5,096 | $366.64 | $1.87M | 18 Nov 2025 | 19 Nov 2025 |
| Mauch Robert P.President & CEO | Sale | 5,097 | $326.80 | $1.67M | 20 Oct 2025 | 21 Oct 2025 |
| Robert P. MauchPresident & CEO | Sale | 5,097 | $326.80 | $1.67M | 20 Oct 2025 | 21 Oct 2025 |
Frequently Asked Questions
What is COR stock price today?
CENCORA INC (COR) is currently trading at $359.86. The stock has a 52-week range of $251.94 to $377.54 and a market capitalization of $70.00B.
Is COR a good stock to buy in 2026?
CENCORA INC has a P/E ratio of 43.3 (forward P/E: 18.3), a dividend yield of 0.67%, and 1-year performance of +38.1%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling COR stock?
There have been 11 insider transactions for COR in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has COR stock performed over the past year?
CENCORA INC (COR) has returned +38.1% over the past 12 months. The stock traded between $251.94 and $377.54 during this period, and is currently at $359.86.
Which hedge funds own COR (CENCORA INC)?
1 tracked hedge funds currently hold COR in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is COR's market cap and valuation?
CENCORA INC (COR) has a market capitalization of $70.00B. The trailing P/E ratio is 43.3 and forward P/E is 18.3. The stock is classified in the Healthcare sector.
What is COR's revenue and profitability?
CENCORA INC reported revenue of $325.78B with net income of $1.63B and a profit margin of 0.00%. The stock has a beta of 0.65.
What sector is COR in and who are its biggest institutional holders?
CENCORA INC (COR) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.